Michael Kaseta is the Chief Financial Officer (CFO) and Chief Operating Officer (COO) at LIQUIDIA CORP, a biopharmaceutical company focused on developing and commercializing innovative products for the treatment of pulmonary hypertension and other diseases. In his dual role, Kaseta is responsible for overseeing the company's financial operations, strategic planning, and operational execution. His leadership has been instrumental in guiding LIQUIDIA through various stages of growth and development, ensuring the company's financial stability and operational efficiency. Prior to joining LIQUIDIA, Kaseta held several high-level financial positions at notable companies within the life sciences industry. He served as CFO at both BioProducts Laboratory Ltd. and Talecris Biotherapeutics, where he played a key role in driving financial performance and supporting corporate growth initiatives. Kaseta's extensive experience in financial management, coupled with his strategic vision, has enabled him to make significant contributions to LIQUIDIA's success. His expertise in navigating complex financial landscapes and his ability to foster strong operational frameworks have been vital in advancing the company's mission to bring life-changing therapies to patients. Under Kaseta's leadership, LIQUIDIA has achieved several milestones, including the advancement of its product pipeline and the establishment of key partnerships. His strategic oversight has been crucial in securing funding and resources necessary for the company's research and development efforts. Kaseta's commitment to excellence and his collaborative approach have solidified his reputation as a respected leader in the biopharmaceutical industry, and his contributions continue to drive LIQUIDIA's progress toward achieving its goals.